Cheche Group Inc.
US ˙ NasdaqCM ˙ KYG207071088

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de N Anthony Coles. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que N Anthony Coles reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:REGN / Regeneron Pharmaceuticals, Inc. Director 1,714
US:CERE / Cerevel Therapeutics Holdings, Inc. Director 0
US:YMTX / Yumanity Therapeutics Inc Executive Chair, Director 78,650
US:MCK / McKesson Corporation Director 0
US:CRSP / CRISPR Therapeutics AG Director 15,000
US:ONXX / Onyx Pharmaceuticals Inc Chairman & CEO, Director 0
US:CCG / Cheche Group Inc. Director 3,999
US:LH / Labcorp Holdings Inc. Director 2,584
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por N Anthony Coles. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas CCG / Cheche Group Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em CCG / Cheche Group Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CCG / Cheche Group Inc. Insider Trades
Vendas Internas CCG / Cheche Group Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em CCG / Cheche Group Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

CCG / Cheche Group Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por N Anthony Coles conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-01-06 2026-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 155 1,714 9.94
2025-01-06 2025-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 166 1,559 11.92
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -10,290 0 -100.00
2024-08-05 2024-08-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
D - Sale to Issuer -15,638 10,290 -60.31
2024-07-03 2024-07-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -25,000 25,928 -49.09 41.18 -1,029,535 1,067,751
2024-07-03 2024-07-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 25,000 50,928 96.42 3.50 87,500 178,248
2024-06-07 2024-06-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
A - Award 10,290 25,928 65.80
2024-06-05 2024-06-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 40.61 -2,030,520 635,065
2024-06-05 2024-06-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-05-14 2024-05-10 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 42.10 -2,105,125 658,399
2024-05-14 2024-05-10 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-04-03 2024-04-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 42.33 -2,116,640 662,000
2024-04-03 2024-04-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-03-06 2024-03-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 41.01 -2,050,550 641,330
2024-03-06 2024-03-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-03-04 2024-02-29 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 15,638 -76.18 41.16 -2,057,890 643,626
2024-03-04 2024-02-29 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 65,638 319.73 3.50 175,000 229,733
2024-02-08 2024-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale -2,506 15,638 -13.81 41.54 -104,110 649,667
2024-02-08 2024-02-06 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise 15,440 18,144 571.01
2024-01-04 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 135 1,393 10.73
2024-01-04 2024-01-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 42.24 -2,111,815 114,207
2024-01-04 2024-01-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-11-16 2023-11-14 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -22,824 2,704 -89.41 25.13 -573,455 67,938
2023-11-16 2023-11-14 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 22,824 25,528 844.08 3.50 79,884 89,348
2023-11-09 2023-11-08 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -100 2,704 -3.57 25.16 -2,516 68,033
2023-11-09 2023-11-08 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 100 2,804 3.70 3.50 350 9,814
2023-11-09 2023-11-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -27,076 2,704 -90.92 25.02 -677,555 67,665
2023-11-09 2023-11-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 27,076 29,780 1,001.33 3.50 94,766 104,230
2023-11-06 2023-11-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -61,401 2,704 -95.78 25.43 -1,561,458 68,764
2023-11-06 2023-11-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 61,401 64,105 2,270.75 3.50 214,904 224,368
2023-11-06 2023-11-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -38,599 2,704 -93.45 25.19 -972,239 68,109
2023-11-06 2023-11-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 38,599 41,303 1,427.48 3.50 135,096 144,560
2023-09-08 2023-09-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 24.07 -1,203,415 65,081
2023-09-08 2023-09-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-07-13 2023-07-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 30.03 -1,501,340 81,192
2023-07-13 2023-07-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-06-05 2023-06-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 32.60 -1,630,070 88,154
2023-06-05 2023-06-01 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -300 2,704 -9.99 32.93 -9,879 89,043
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -12,132 3,004 -80.15 31.76 -385,287 95,401
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -37,568 15,136 -71.28 31.36 -1,178,268 474,719
2023-05-08 2023-05-04 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-04-13 2023-04-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -50,000 2,704 -94.87 25.06 -1,253,130 67,769
2023-04-13 2023-04-11 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-03-06 2023-03-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -3,000 2,704 -52.59 27.19 -81,570 73,522
2023-03-06 2023-03-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 3,000 5,704 110.95 3.50 10,500 19,964
2023-03-06 2023-03-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -47,000 2,704 -94.56 27.11 -1,274,377 73,317
2023-03-06 2023-03-02 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 47,000 49,704 1,738.17 3.50 164,500 173,964
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -7,942 2,704 -74.60 33.57 -266,649 90,785
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -42,058 10,646 -79.80 33.04 -1,389,752 351,783
2023-02-08 2023-02-07 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -500 2,704 -15.61 30.73 -15,366 83,099
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -49,500 3,204 -93.92 29.93 -1,481,505 95,894
2023-01-06 2023-01-05 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2023-01-05 2023-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 165 1,258 15.10
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -311 1,093 -22.15 716.08 -222,701 782,675
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,266 1,404 -61.74 715.48 -1,621,278 1,004,534
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,022 3,670 -21.78 714.61 -730,331 2,622,619
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,198 4,692 -20.34 713.66 -854,965 3,348,493
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100 5,890 -1.67 711.95 -71,195 4,193,386
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -679 5,990 -10.18 710.63 -482,518 4,256,674
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 6,669 -0.01 709.92 -710 4,734,456
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -181 6,670 -2.64 707.87 -128,124 4,721,493
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,613 6,851 111.58 482.68 1,743,923 3,306,841
2022-12-30 2022-12-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,145 3,238 196.25 374.12 802,487 1,211,401
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -5,145 2,704 -65.55 27.09 -139,395 73,260
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
S - Sale X -44,855 7,849 -85.11 26.62 -1,193,906 208,917
2022-12-13 2022-12-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Common Stock
M - Exercise X 50,000 52,704 1,849.11 3.50 175,000 184,464
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -602 1,093 -35.52 584.57 -351,911 638,935
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,045 1,695 -38.14 583.16 -609,402 988,456
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,220 2,740 -30.81 582.56 -710,723 1,596,214
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -822 3,960 -17.19 581.44 -477,944 2,302,502
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -688 4,782 -12.58 580.44 -399,343 2,775,664
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -550 5,470 -9.14 579.85 -318,918 3,171,780
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -273 6,020 -4.34 578.25 -157,862 3,481,065
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -500 6,293 -7.36 577.07 -288,535 3,631,502
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,784 6,793 125.76 371.40 1,405,378 2,522,920
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 3,009 -9.07 576.73 -173,019 1,735,381
2022-09-08 2022-09-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,216 3,309 202.74 374.12 829,050 1,237,963
2022-02-11 2022-02-09 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 425,772 425,772
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 2,707 2,707
2022-01-05 2022-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 191 1,093 21.18
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -6,909 0 -100.00
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,039 0 -100.00
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,174 902 -56.55 664.32 -779,912 599,217
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -905 2,076 -30.36 663.73 -600,676 1,377,903
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3 2,981 -0.10 662.55 -1,988 1,975,062
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,344 2,984 -52.84 661.56 -2,212,257 1,974,095
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -448 6,328 -6.61 660.78 -296,029 4,181,416
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 6,776 -4.24 659.00 -197,700 4,465,384
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -935 7,076 -11.67 658.65 -615,838 4,660,607
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -835 8,011 -9.44 657.53 -549,038 5,267,473
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,400 8,846 -13.66 656.48 -919,072 5,807,222
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -403 10,246 -3.78 655.14 -264,021 6,712,564
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -800 10,649 -6.99 653.31 -522,648 6,957,098
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,101 11,449 -8.77 652.95 -718,898 7,475,625
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -300 12,550 -2.33 651.36 -195,408 8,174,568
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,039 12,850 64.51 345.47 1,740,823 4,439,290
2021-09-17 2021-09-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6,909 7,811 765.96 380.95 2,631,984 2,975,600
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -5,100 5,039 -50.30
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,100 902 -84.97 650.00 -3,315,000 586,300
2021-08-19 2021-08-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5,100 6,002 565.41 345.47 1,761,897 2,073,511
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -900 10,139 -8.15
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -900 902 -49.94 650.00 -585,000 586,300
2021-08-19 2021-08-17 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 900 1,802 99.78 345.47 310,923 622,537
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -2,000 11,039 -15.34
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 902 -68.92 625.00 -1,250,000 563,750
2021-08-16 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2,000 2,902 221.73 345.47 690,940 1,002,554
2021-04-02 2021-04-01 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 78,650 78,650
2021-02-05 2021-02-03 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 732,714 732,714
2021-02-03 2021-02-01 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 1,118 691,008 0.16
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 3,613 3,613
2021-01-05 2021-01-04 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 248 902 37.92
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Warrant (Right to Buy)
A - Award 6,038 6,038
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 12,082 12,082
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Stock Option (Right to Buy)
A - Award 72,496 72,496
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 52,669 52,669
2020-12-28 2020-12-22 4 YMTX YUMANITY THERAPEUTICS, INC.
Common Stock
A - Award 689,890 689,890
2020-11-13 2020-11-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -11 13,039 -0.08
2020-11-13 2020-11-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11 654 1.71 345.47 3,800 225,937
2020-10-30 2020-10-28 4 CERE Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 196,335 196,335
2020-08-19 2020-08-17 4 MCK MCKESSON CORP
Common Stock
S - Sale -2,453 0 -100.00 156.77 -384,559
2020-07-31 2020-07-29 4 MCK MCKESSON CORP
Common Stock
A - Award 1,157 2,453 89.27
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 4,361 4,361
2020-01-06 2020-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 320 643 99.07
2019-08-01 2019-07-31 4 MCK MCKESSON CORP
Common Stock
A - Award 1,296 1,296
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 3,784 3,784
2019-01-04 2019-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 323 323
2018-09-04 2018-08-31 4 MCK MCKESSON CORP
Common Stock
S - Sale X -1,350 0 -100.00 128.69 -173,732
2018-07-26 2018-07-25 4 MCK MCKESSON CORP
Common Stock
A - Award 1,350 1,350
2018-01-04 2018-01-02 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 6,909 6,909
2017-07-27 2017-07-26 4 MCK MCKESSON CORP
Restricted Stock Units (RSUs)
A - Award 1,083 1,083
2017-06-02 2017-05-31 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15,000 15,000
2017-01-31 2017-01-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 13,050 13,050
2016-10-26 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
A - Award 35,000 70,000 100.00 14.00 490,000 980,000
2016-10-26 2016-10-24 4 CRSP CRISPR Therapeutics AG
Common Stock
A - Award 35,000 70,000 100.00 14.00 490,000 980,000
2016-10-20 2016-10-18 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 15,000 15,000
2016-07-28 2016-07-27 4 MCK MCKESSON CORP
Restricted Stock Units (RSUs)
A - Award 915 915
2015-07-31 2015-07-29 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 794 794
2014-07-31 2014-07-30 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 785 785
2014-05-16 2014-05-15 4 MCK MCKESSON CORP
Restricted Stock Units
A - Award 212 212
2014-05-01 3 MCK MCKESSON CORP
Common Stock
0
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -75,300 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -139,947 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2,653 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -45,283 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -2,842 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -143,698 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -3,302 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Stock Options
D - Sale to Issuer -5,247 0 -100.00
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -105,566 0 -100.00 125.00 -13,195,750
2013-10-03 2013-10-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
U - Other -25,632 105,566 -19.54 125.00 -3,204,000 13,195,750
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -6,562 48,125 -12.00
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -6,562 131,198 -4.76 90.00 -590,580 11,807,820
2013-06-07 2013-06-05 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 6,562 137,760 5.00 35.18 230,851 4,846,397
2013-05-31 2013-04-22 4 CCG Campus Crest Communities, Inc.
Common Stock
D - Sale to Issuer -16,335 3,999 -80.33
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -3,502 5,247 -40.03
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -13,776 0 -100.00
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 3,502 131,198 2.74 28.55 99,982 3,745,703
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 13,776 127,696 12.09 29.03 399,917 3,707,015
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -1,300 113,920 -1.13 90.81 -118,053 10,345,075
2013-04-03 2013-04-03 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8,405 115,220 -6.80 89.30 -750,566 10,289,146
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -7,859 123,625 -5.98 86.14 -676,974 10,649,058
2013-04-03 2013-04-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -3,770 131,484 -2.79 86.14 -324,748 11,326,032
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 75,300 75,300
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10,938 54,687 -16.67
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 26,800 135,254 24.71
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -10,938 108,454 -9.16 90.00 -984,420 9,760,860
2013-04-01 2013-03-28 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 10,938 119,392 10.09 35.18 384,799 4,200,211
2013-02-19 2013-02-15 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -216 2,584 -7.71
2013-01-31 2013-01-31 4 CCG Campus Crest Communities, Inc.
Common Stock
A - Award 7,000 20,334 52.50
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -39,375 65,625 -37.50
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -86,224 13,776 -86.22
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -125,599 108,343 -53.69
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 39,375 233,942 20.24 35.18 1,385,212 8,230,080
2012-10-17 2012-10-16 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 86,224 194,567 79.58 29.03 2,503,083 5,648,280
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
StockOption (Right to Buy)
M - Exercise -250,000 100,000 -71.43
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale -270,690 108,343 -71.42 72.18 -19,538,404 7,820,198
2012-08-09 2012-08-08 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
M - Exercise 250,000 379,033 193.75 29.03 7,257,500 11,003,328
2012-08-03 2012-08-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -8,820 154,033 -5.42 74.37 -655,943 11,455,434
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -11,883 162,853 -6.80 73.97 -879,007 12,046,530
2012-05-29 2012-05-24 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 1,800 2,800 180.00
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -2,406 174,330 -1.36 36.58 -88,007 6,376,660
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -3,368 176,736 -1.87 36.58 -123,192 6,464,526
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -2,406 180,104 -1.32 36.58 -88,004 6,587,646
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 142,600 142,600
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 60,100 182,510 49.10
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 28,000 122,410 29.66
2012-03-29 2012-03-28 4 CCG Campus Crest Communities, Inc.
Common Stock
A - Award 6,667 13,334 100.00
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)